RxDoctor Payments Data

Kelly Kaldenbach

Physician Assistant · Weatherford, TXNPI 1679687206

Payments from drug & device makers

$18,973in general payments, 2019–2025

Across 1,029 payments — averaging $18.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Novo Nordisk$2K
  • Teva Pharmaceuticals USA, Inc.$2K
  • AstraZeneca$1K
  • Lilly USA, LLC$1K
  • GSK$978
  • plus $10K from 54 others

What the payments were for

  • Food & beverage$18,973100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie153$2,318
Novo Nordisk72$1,584
Teva Pharmaceuticals USA, Inc.78$1,524
AstraZeneca47$1,455
Lilly USA, LLC66$1,007
GSK44$978
Pfizer78$905
Amgen37$881
Otsuka America Pharmaceutical, Inc.42$870
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)52$847
Corium, LLC31$499
Antares Pharma, Inc.24$456
Sumitomo Pharma America, Inc.25$440
Boehringer Ingelheim22$390
Mylan Specialty L.p.16$378
Lundbeck LLC29$362
Astellas Pharma US Inc15$350
Bayer11$271
Abbott15$229
Merck13$209
Sanofi-aventis U.S. LLC11$206
Nestle Healthcare Nutrition Inc.6$195
Alkermes, Inc.8$178
Exact Sciences9$168
Ironshore Pharmaceuticals Inc.9$159
Takeda Pharmaceuticals U.S.A., Inc.9$157
Kowa Pharmaceuticals America, Inc.8$155
Paratek Pharmaceuticals, Inc.3$150
Aimmune Therapeutics, Inc.3$146
Vivus LLC7$129
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC7$105
Idorsia Pharmaceuticals US Inc5$90
Tris Pharma Inc6$90
Biohaven Pharmaceuticals, Inc.5$87
Halozyme Inc4$73
Collegium Pharmaceutical, Inc.4$64
Biohaven Pharmaceutical Holding Company Ltd.4$62
Eisai Inc.3$62
Adlon Therapeutics L.p.4$59
Cranial Technologies, Inc4$55
Medtronic3$50
Genentech USA, Inc.8$49
Amarin Pharma, Inc.3$41
Viatris Specialty LLC2$41
IBSA Pharma Inc.2$40
Esperion Therapeutics, Inc.2$38
Organon1$33
Tolmar, Inc.2$32
Johnson & Johnson2$31
Dexcom, Inc.2$30
Xeris Pharmaceuticals, Inc.2$29
RGH Enterprises LLC1$28
Lucid Diagnostics Inc.1$25
Bioventus LLC1$25
Supernus Pharmaceuticals, Inc.1$24
GRT US Holding, Inc.1$21
Vanda Pharmaceuticals Inc.1$19
Ultragenyx Pharmaceutical Inc.1$19
Novartis1$15
Noven Therapeutics, LLC1$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$18,973 in reported general payments places this provider in the 95th percentile of 8,308 physician assistant providers in Texas.

See all physician assistant providers in Texas

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide53$80,104
MounjaroTirzepatide56$58,400
BiktarvyBictegrav/Emtricit/Tenofov Ala11$50,975
EliquisApixaban35$48,949
RybelsusSemaglutide27$43,892
FarxigaDapagliflozin Propanediol32$39,951
JardianceEmpagliflozin31$37,603
Omnipod Dash Pods (Gen 4)Insulin Pump Cart,cont Inf,bt11$34,176
RexultiBrexpiprazole12$25,415
BelsomraSuvorexant39$19,344
MyrbetriqMirabegron17$17,803
Trelegy ElliptaFluticasone/Umeclidin/Vilanter16$16,223
Breztri AerosphereBudesonide/Glycopyr/Formoterol15$15,683
Emgality PenGalcanezumab-Gnlm17$14,045
LinzessLinaclotide13$12,134

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$1,584$123,99680 claims
AstraZenecaFarxiga, Breztri Aerosphere, Symbicort$1,455$60,37462 claims
Lilly USA, LLCMounjaro$1,007$58,40056 claims
PfizerEliquis, Premarin$905$52,32950 claims
Boehringer IngelheimJardiance$390$37,60331 claims
Otsuka America Pharmaceutical, Inc.Rexulti$870$25,41512 claims
MerckBelsomra$209$19,34439 claims
Astellas Pharma US IncMyrbetriq$350$17,80317 claims
GSKTrelegy Ellipta$978$16,22316 claims
AbbVieLinzess$2,318$12,13413 claims
Sumitomo Pharma America, Inc.Gemtesa$440$7,40012 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 8,308 physician assistant providers in Texas.

Other physician assistant in Weatherford

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →